The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
The co-morbidity of depression and epilepsy: Epidemiology, etiology, and treatment
Abstract
Co-morbid depression is common in patients with epilepsy and is often undiagnosed. The manifestation of depression in epilepsy is multifaceted with many interacting neurobiological and psychosocial determinants, including clinical features of epilepsy (seizure frequency, type, foci, or lateralization of foci) and neurochemical or iatrogenic mechanisms. Depression is reported more frequently in patients with temporal lobe epilepsy (TLE) and left-sided foci, although not all studies support this finding. In patients with depression and epilepsy, optimal control of seizures should be attained first and foremost with appropriate anticonvulsant treatments including antiepileptic drugs (AEDs) and vagus nerve stimulation (VNS) therapy. Some anticonvulsant treatments (VNS, valproate, carbamazepine, lamotrigine, and gabapentin) have demonstrated mood improvement in epilepsy patients and may have therapeutic potential for this patient population. When antidepressants are necessary to treat depression in patients with epilepsy, selective serotonin reuptake inhibitors (SSRIs) and multireceptor antidepressants are considered first-line treatments. Electroconvulsive therapy is not contraindicated for treatment-resistant or psychotic depression. Depression must be recognized, diagnosed, and adequately treated in patients with epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Ben‐Menachem, E., Mañon‐Espaillat, R., Ristanovic, R., Wilder, B. J., Stefan, H., Mirza, W., Tarver, W. B., Wernicke, J. F., & First International Vagus Nerve Stimulation Study Group (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02482.x · Cited by 683
Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., McElroy, S. L., Kusumakar, V., Ascher, J. A., Earl, N. L., Greene, P. L., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1106 · Cited by 498
Prospective Long‐Term Study of Vagus Nerve Stimulation for the Treatment of Refractory Seizures
DeGiorgio, C. M., Schachter, S. C., Handforth, A., Salinsky, M., Thompson, J., Uthman, B., Reed, R., Collin, S., Tecoma, E., Morris, G. L., et al. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00325.x · Cited by 479
Enhancement of recovery from psychiatric illness by methylfolate
Godfrey, P. S. A., Toone, B. K., Bottiglien, T., Laundy, M., Reynolds, E. H., Carney, M. W. P., Flynn, T. G., & Chanarin, I. (1990) · The Lancet · doi:10.1016/0140-6736(90)91942-4 · Cited by 389
Cited by
Motamedi, G., & Meador, K. (2003) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.07.004 · Cited by 302
De Weerd, A., De Haas, S., Otte, A., Trenité, D. K., Van Erp, G., Cohen, A., De Kam, M., & Van Gerven, J. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.46703.x · Cited by 268
Miller, J. M., Kustra, R. P., Vuong, A., Hammer, A. E., & Messenheimer, J. A. (2008) · Drugs · doi:10.2165/00003495-200868110-00003 · Cited by 65
Hippocampal plasticity after a vagus nerve injury in the rat.
(2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.14.003 · Cited by 23
Metadata
- Authors
- Harden, C. L.
- Venue
- Neurology
- Published
- 2002-09-24
- Volume
- 59
- Issue
- 6_suppl_4
- Pages
- S48-55
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2077805222
- Cited by
- 159
- References
- 5
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The co-morbidity of depression and epilepsy: Epidemiology, etiology, and treatment. https://app.cochat.ai/papers/10.1212/wnl.59.6_suppl_4.s48
- The paper
- Harden, C. L. (2002). The co-morbidity of depression and epilepsy: Epidemiology, etiology, and treatment. Neurology. https://doi.org/10.1212/wnl.59.6_suppl_4.s48
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.